These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2200680)

  • 1. Current role of gallium scanning in the management of lymphoma.
    McLaughlin AF; Magee MA; Greenough R; Allman KC; Southee AE; Meikle SR; Hutton BF; Joshua DE; Bautovich GJ; Morris JG
    Eur J Nucl Med; 1990; 16(8-10):755-71. PubMed ID: 2200680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
    Ulusakarya A; Lumbroso J; Casiraghi O; Koscielny S; Vantelon JM; Girinsky T; Tardivon A; Bourhis JH; Dartevelle P; Pico JL; Munck JN
    Leuk Lymphoma; 1999 Nov; 35(5-6):579-86. PubMed ID: 10609795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
    Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
    Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography scanning in the assessment of patients with lymphoma.
    Foo SS; Mitchell PL; Berlangieri SU; Smith CL; Scott AM
    Intern Med J; 2004 Jul; 34(7):388-97. PubMed ID: 15271172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?
    Maisey NR; Hill ME; Webb A; Cunningham D; Flux GD; Padhani A; Ott RJ; Norman A; Bishop L
    Eur J Cancer; 2000 Jan; 36(2):200-6. PubMed ID: 10741278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.
    Wirth A; Seymour JF; Hicks RJ; Ware R; Fisher R; Prince M; MacManus MP; Ryan G; Januszewicz H; Wolf M
    Am J Med; 2002 Mar; 112(4):262-8. PubMed ID: 11893364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients.
    Front D; Israel O
    Semin Nucl Med; 1995 Jan; 25(1):60-71. PubMed ID: 7716559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bulky mediastinal lymphomas: role of magnetic resonance and SPECT-Ga-67 in the evaluation of residual masses].
    Canini R; Battista G; Monetti N; Pisi P; Fanti S; Zinzani PL; Zompatori M; Bendandi M; Gherlinzoni F; Corinaldesi A
    Radiol Med; 1995 Oct; 90(4):448-56. PubMed ID: 8552823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.
    Janicek M; Kaplan W; Neuberg D; Canellos GP; Shulman LN; Shipp MA
    J Clin Oncol; 1997 Apr; 15(4):1631-7. PubMed ID: 9193363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of FDG-PET in malignant lymphoma.
    Becherer A; Jaeger U; Szabo M; Kletter K
    Q J Nucl Med; 2003 Mar; 47(1):14-21. PubMed ID: 12714950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients.
    Ionescu I; Brice P; Simon D; Guermazi A; Leblanc T; Rousselot P; Gossot D; Meignin V; Gisselbrecht C; Rain JD
    Med Oncol; 2000 May; 17(2):127-34. PubMed ID: 10871819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ga-67 SPECT before and after treatment of lymphoma.
    Front D; Israel O; Epelbaum R; Ben Haim S; Sapir EE; Jerushalmi J; Kolodny GM; Robinson E
    Radiology; 1990 May; 175(2):515-9. PubMed ID: 2183289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallium-67 scintigraphy in the management: Hodgkin's disease and non-Hodgkin's lymphoma.
    Rehm PK
    Cancer Biother Radiopharm; 1999 Aug; 14(4):251-62. PubMed ID: 10850311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY; Kao A; Yen RF
    Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease.
    King SC; Reiman RJ; Prosnitz LR
    J Clin Oncol; 1994 Feb; 12(2):306-11. PubMed ID: 8113837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallium scanning in the management of mediastinal Hodgkin's disease.
    Wylie BR; Southee AE; Joshua DE; McLaughlin AF; Gibson J; Hutton BF; Morris JG; Kronenberg H
    Eur J Haematol; 1989 Apr; 42(4):344-7. PubMed ID: 2721659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Semiology of the exploration of residual masses in the mediastinum using imaging techniques].
    Pallardó Calatayud Y; Ferrer Puchol MD; García Conde J
    Sangre (Barc); 1998 Feb; 43(1):83-6. PubMed ID: 9577187
    [No Abstract]   [Full Text] [Related]  

  • 18. Three cases demonstrating the role of gallium scanning in relapsing Hodgkin's disease and non-Hodgkin lymphoma.
    Zollars LE; Nagel JS; Tumeh SS
    J Nucl Med; 1987 Oct; 28(10):1611-5. PubMed ID: 3655913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma.
    Gasparini MD; Balzarini L; Castellani MR; Tesoro Tess JD; Maffioli LS; Petrillo R; Ceglia E; Musumeci R; Buraggi GL
    Cancer; 1993 Jul; 72(2):577-82. PubMed ID: 8319190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma.
    Vose JM; Bierman PJ; Anderson JR; Harrison KA; Dalrymple GV; Byar K; Kessinger A; Armitage JO
    J Clin Oncol; 1996 Sep; 14(9):2473-9. PubMed ID: 8823325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.